scholarly journals Clinical Impact of MALDI-TOF MS Identification and Rapid Susceptibility Testing on Adequate Antimicrobial Treatment in Sepsis with Positive Blood Cultures

PLoS ONE ◽  
2016 ◽  
Vol 11 (5) ◽  
pp. e0156299 ◽  
Author(s):  
Alexia Verroken ◽  
Lydwine Defourny ◽  
Olivier le Polain de Waroux ◽  
Leïla Belkhir ◽  
Pierre-François Laterre ◽  
...  
PLoS ONE ◽  
2016 ◽  
Vol 11 (9) ◽  
pp. e0160537 ◽  
Author(s):  
Alexia Verroken ◽  
Lydwine Defourny ◽  
Olivier le Polain de Waroux ◽  
Leïla Belkhir ◽  
Pierre-François Laterre ◽  
...  

PLoS ONE ◽  
2018 ◽  
Vol 13 (10) ◽  
pp. e0205603 ◽  
Author(s):  
Marlène Sauget ◽  
Xavier Bertrand ◽  
Didier Hocquet

Author(s):  
Neele J. Froböse ◽  
Evgeny A. Idelevich ◽  
Frieder Schaumburg

When blood cultures are flagged as positive, they are incubated on solid media to produce enough biomass of the bacterium for identification and susceptibility testing. Rapid turnaround times for laboratory results could save lives, and we wanted to assess which solid medium is best to shorten the time to species identification using MALDI-TOF mass spectrometry.


2017 ◽  
Vol 55 (12) ◽  
pp. 3328-3338 ◽  
Author(s):  
Matthew L. Faron ◽  
Blake W. Buchan ◽  
Nathan A. Ledeboer

ABSTRACTEarly initiation of effective antibiotics for septic patients is essential for patient survival. Matrix-assisted desorption ionization–time of flight mass spectrometry (MALDI-TOF MS) has revolutionized clinical microbiology for isolate identification and has the possibility to impact how blood culture testing is performed. This review discusses the various uses of MALDI-TOF MS for the identification and susceptibility testing of positive blood cultures, the performance of these methods, and the outcomes involved with its implementation.


Sign in / Sign up

Export Citation Format

Share Document